摘要
目的讨论0.5%马来酸噻吗洛尔外用婴幼儿血管瘤的临床疗效及安全性.方法我院在2017年1月-2018年1月诊断婴幼儿血管瘤的2个月以内的婴幼儿60例,局部外用0.5%马来酸噻吗洛尔滴眼液涂至瘤体表面,连续观察3个月根据患儿瘤体的大小、颜色、表面张力等进行评估,以及不良反应的记录.结果疗效评定:优15例,好27例,中11例,差5例,另外有2例患儿因血糖低,嗜睡等不良反应而停止用药.结论0.5%马来酸噻吗洛尔治疗婴幼儿血管瘤疗效明显,不良反应少,患儿耐受性好,是治疗婴幼儿血管瘤一种有效的、安全的治疗手段.
Objective To discuss the clinical efficacy and safety of 0.5 % malaric acid in small infant hemangioma. Methods 60 cases of infant hemangioma were diagnosed in our hospital within 2 months from January 2017 to January 2018, and 0.5 % of the thiolor maleate eye drops were applied to the surface of the tumor. According to the tumor body size, color, surface tension, etc., the evaluation was conducted for 3 months. And a record of adverse reactions. Results The evaluation of curative effect: excellent 15 cases, good 27 cases, 11 cases, difference 5 cases, 2 children with low blood sugar, lethargy and other adverse effects, and stopped the drug. Conclusion 0.5 % malaric acid is an effective and safe treatment for small infant hemangioma with obvious curative effect, little adverse reaction and good tolerance.
作者
邹筠
袁华
付荣华
金平亮
谭梅军
ZOU Yun;YUAN Hua;FU Rong-hua;JIN Ping-liang;TAN Mei-jun(Department of Plastic Surgery,Jiangxi Children's Hospital,Jiangxi Province,330006,China;Guangdong Provincial Women and Children's Health Hospital Plastic Beauty Center,Guangdong Province,510010,China)
出处
《中国医疗美容》
2019年第9期57-60,共4页
China Medical Cosmetology
基金
江西省卫生计生委科技计划项目(编号：20175497)
